Disclosure under Takeovers Panel GN 20
Released
Released
Announcement PDF
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
www.alteritytherapeutics.com
ASX ANNOUNCEMENT 13 November 2025
Disclosure under Takeovers Panel Guidance
Note 20: Equity Derivatives
Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) (“the Company”) advises
that it has received the attached notice from Regal Funds Management Asia Pte Limited which was
provided to the Company pursuant to the Australian Takeovers Panel Guidance Note 20 – Equity
Derivatives.
Authorised for release by:
Abby Macnish Niven
Company Secretary
Alterity Therapeutics Limited
For further information please contact:
Investors
Remy Bernarda
Investor Relations Advisory Solutions
ir@alteritytx.com
+1 (415) 203-6386
12-November-2025
Dear Alterity Therapeutics ltd,
Identity of the taker: Amazon Market Neutral Fund Zambezi Absolute Return Fund
Relevant security:
Price (including reference price,
strike price, option price etc as
appropriate):
Any material changes to information
previously disclosed:
No information previously
disclosed
Previous disclosure of below
5% on 31-Jul-2024
Relevant interests in securities:
Long equity derivative positions and
relevant interests held by the taker
and its associates:
Short equity derivative positions
that offset physical positions:
Short positions of more than 1% that
have been acquired after a long
position is disclosed, whether by
notice or substantial holding notice:
Yours sincerely
Greg Laughlin
Chief Executive Officer
Regal Funds Management Asia Pte Limited
Disclosure of Long Equity Derivative Positions
Entry date and number of securities
to which the derivative relates:
Ordinary shares in Alterity Therapeutics ltd
None
The Funds have no other associates with a long equity
derivative position or relevant interest in the company
None
None
We refer to Guidance Note 20: Equity Derivatives (GN20), issued by the Australian Takeovers
Panel. Terms not defined in this notice have the meanings given to them in GN20.
GN20 relevantly provides that the non-disclosure of long positions, including long equity
derivative positions, may give rise to unacceptable circumstances. Regal Funds Management Asia
Pte Limited, as investment manager of Amazon Market Neutral Fund and Zambezi Absolute Return
Fund (the Funds), discloses the following information on behalf of the Funds.
Not applicable
Total number of securities
to which derivatives relate
as at 10-Nov-2025:
50,000,000 (0.46%)
Total number of securities
to which derivatives relate
as at 10-Nov-2025:
503,141,403 (4.63%)
Regal Funds Management Asia Pte Limited T +65 6654 1755 80
Raffles Place #26-23 UOB Plaza 2
Singapore 048624
Share your feedback
Discover